Endocarditis

Urgent Voluntary Recall of D&D Commodities Ltd.

Retrieved on: 
Thursday, January 4, 2024

D&D Commodities Ltd. is taking immediate action to remove the product from retail distribution centers and to fully investigate the cause.

Key Points: 
  • D&D Commodities Ltd. is taking immediate action to remove the product from retail distribution centers and to fully investigate the cause.
  • Consumers with questions may contact D&D Commodities Ltd. at 1-218-991-8015, Monday through Friday, 8:00 am to 5:00 pm CST.
  • D&D Commodities Ltd. has chosen to issue a voluntary recall of this product and is committed to providing high-quality, safe products for wild and domesticated birds and the people who love them.
  • This is a voluntary recall being conducted in cooperation with the FDA.

Fluvanna Women's Prison in Virginia Ignores Inmate Jennifer Emmi's Reports of Heart Attack Symptoms

Retrieved on: 
Thursday, December 21, 2023

Over the past seven days, Jennifer has submitted five separate Emergency Grievances with the prison begging for treatment of symptoms commonly associated with heart attacks.

Key Points: 
  • Over the past seven days, Jennifer has submitted five separate Emergency Grievances with the prison begging for treatment of symptoms commonly associated with heart attacks.
  • These reports indicate that Jennifer is experiencing pain radiating down her left arm and chest, fatigue and difficulty walking.
  • On Thursday December 14, Jennifer was taken to a cardiologist at the University of Virginia for treatment.
  • Following this visit, the prison has reportedly not taken any action to treat Jennifer's growing cardiac-related symptoms.

Mid America Pet Food Expands Voluntary Recall to Include Additional Dog and Cat Food Products Due to Possible Salmonella Health Risk

Retrieved on: 
Thursday, November 9, 2023

MOUNT PLEASANT, Texas, Nov. 9, 2023 /PRNewswire/ -- Mid America Pet Food, Mount Pleasant, Texas, is expanding its October 30, 2023, voluntary recall to include additional pet food products, with Best By Dates before 10/31/24, made at its Mount Pleasant facility, due to the products' potential to be contaminated with Salmonella.

Key Points: 
  • MOUNT PLEASANT, Texas, Nov. 9, 2023 /PRNewswire/ -- Mid America Pet Food, Mount Pleasant, Texas, is expanding its October 30, 2023, voluntary recall to include additional pet food products, with Best By Dates before 10/31/24, made at its Mount Pleasant facility, due to the products' potential to be contaminated with Salmonella.
  • Salmonella can affect animals eating the products, and there is risk to humans from handling contaminated pet products, especially if they have not thoroughly washed their hands after having contact with the products or any surfaces exposed to these products.
  • Rarely, Salmonella can result in more serious ailments, including arterial infections, endocarditis, arthritis, muscle pain, eye irritation, and urinary tract symptoms.
  • Voluntarily recalled brands produced at the Mount Pleasant facility include: Victor Super Premium Dog Foods, Wayne Feeds Dog Food, Eagle Mountain Pet Food, and some Member's Mark varieties with Best By Dates before 10/31/24.

PHAXIAM Therapeutics obtains authorizations to launch its phase 1 study in endocarditis infections caused by Staphylococcus aureus

Retrieved on: 
Tuesday, October 24, 2023

Endocarditis is an infection of the endocardium (inner lining of the heart) and valves, usually caused by bacteria.

Key Points: 
  • Endocarditis is an infection of the endocardium (inner lining of the heart) and valves, usually caused by bacteria.
  • The main cause of endocarditis infections, S. aureus, is responsible for around 30%1 of cases.
  • Pascal Birman, Chief Medical Officer of PHAXIAM Therapeutics, stated: "This phase 1 study was designed primarily to assess the safety and pharmacokinetics of our anti-S. aureus phages in the treatment of endocarditis infections.
  • The treatment of endocarditis infections caused by S. aureus using phage therapy could thus offer a major alternative and hope to many patients who have reached a therapeutic impasse.”

What your hands say about your health

Retrieved on: 
Thursday, August 24, 2023

Your hands reveal a lot about the state of your health.

Key Points: 
  • Your hands reveal a lot about the state of your health.
  • This is something that has been recognised since at least the time of Hippocrates – the father of modern medicine.
  • The ancient Greek physician first described “clubbing” in a patient with empyema (where pus fills the space between the lungs and the membrane around it) in the fifth century BC.
  • Clubbing is where the nail looks like an upside-down spoon, and it is still recognised as a sign of disease.

Palms

    • If you find your palms are becoming sweaty in the absence of nervousness, hot temperatures or exercise, it could be down to faulty nerve signals causing the sweat glands to become active.
    • But unexplained sweaty palms – and face, neck and armpits – can be a sign of thyroid problems.
    • Excess of this hormone causes bodily processes to speed up and can be the cause of sweaty palms.
    • A more concerning palm change is the appearance of small areas of red or purple discolouration on the palms of the hands and fingers.

Pins and needles

    • If you experience pins and needles in your hand that you can’t shake off, it might be a sign that you have carpal tunnel syndrome.
    • Pins and needles in the hand can also be a sign of diabetes.
    • Everyone experiences pins and needles at some point, but if you get it a lot or it lasts a long time, you should see your doctor.

Finger length

    • The length of the index versus ring finger varies in men and women.
    • In women, they are fairly equal in length, but in men, the ring finger is typically longer than the index finger.

ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics

Retrieved on: 
Monday, June 26, 2023

Lyon (France) and Cambridge (MA, US), June 26, 2023 – ERYTECH (Nasdaq & Euronext: ERYP) and PHERECYDES announce merger and name change to PHAXIAM Therapeutics, a clinical-stage biopharmaceutical company developing innovative extended bacteriophage therapies to target antimicrobial resistance (AMR).

Key Points: 
  • Lyon (France) and Cambridge (MA, US), June 26, 2023 – ERYTECH (Nasdaq & Euronext: ERYP) and PHERECYDES announce merger and name change to PHAXIAM Therapeutics, a clinical-stage biopharmaceutical company developing innovative extended bacteriophage therapies to target antimicrobial resistance (AMR).
  • “In February this year, we announced our strategic plans with PHERECYDES, with the intent to build a global leader in phage therapy and address the huge medical need caused by antimicrobial resistance.
  • I am very pleased that this merger has now been approved with a large majority by our shareholders”, said Gil Beyen, former Chief Executive Officer of ERYTECH.
  • The board of directors of PHAXIAM is composed of an equal number of directors from the former ERYTECH and PHERECYDES boards (without casting vote for the Chair), and is constituted of:

New Research Uncovers Vascular Benefits of Peanut Consumption on Young Adults

Retrieved on: 
Wednesday, April 19, 2023

The research, which was recently published in the journal Antioxidants and shared by The Peanut Institute , discusses a preventive medicine approach for younger generations.

Key Points: 
  • The research, which was recently published in the journal Antioxidants and shared by The Peanut Institute , discusses a preventive medicine approach for younger generations.
  • The six-month study conducted by the University of Barcelona involved 63 healthy young adults ages 18-33 who included a single serving of peanuts or peanut butter in their regular, daily diet.
  • "There's an urgent need to focus cardiovascular disease education and prevention efforts on young adults," says Dr. Sterling.
  • "Urinary Phenolic Metabolites Associated with Peanut Consumption May Have a Beneficial Impact on Vascular Health Biomarkers ".

DNA ConneXions® Announces Most Accurate At-Home Lyme Disease Test Three Years in a Row and Presents Three New Test Panels

Retrieved on: 
Wednesday, April 12, 2023

The Periodontal Health (Red Complex) Test Panel is comprised of bacteria that are known to cause severe periodontal disease as well as a number of other chronic conditions that impact cardiovascular and metabolic health.

Key Points: 
  • The Periodontal Health (Red Complex) Test Panel is comprised of bacteria that are known to cause severe periodontal disease as well as a number of other chronic conditions that impact cardiovascular and metabolic health.
  • The Whole-Body Health Test Panel was designed to provide a map of whole-body health beginning in the oral cavity.
  • Laboratory director, Dr. Leslie Douglas stated, "At DNA ConneXions® we are continuing to enhance our testing with superior quality, technology, and innovation.
  • The DNA ConneXions® test panels can be utilized without a doctor's order and are performed with a simple, non-invasive dental Super Floss in the comfort of your own home.

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension, USP 750mg/5mL due to Potential Bacillus cereus Contamination in the Product

Retrieved on: 
Tuesday, March 14, 2023

PISCATAWAY, N.J., March 14, 2023 /PRNewswire/ -- Camber Pharmaceuticals, Inc. is voluntarily recalling lot # E220182 of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the potential Bacillus cereus contamination in the product.

Key Points: 
  • PISCATAWAY, N.J., March 14, 2023 /PRNewswire/ -- Camber Pharmaceuticals, Inc. is voluntarily recalling lot # E220182 of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the potential Bacillus cereus contamination in the product.
  • To date, Camber has not received any reports of adverse events related to this recall.
  • Atovaquone Oral Suspension, USP was distributed Nationwide to Wholesalers, Distributors, Retail Pharmacies, and Mail Order Pharmacies.
  • Consumers with questions regarding this recall can contact Inmar by phone at 1-877-597-0878 or email [email protected] , Monday – Friday, 9am – 5pm Eastern Time.

New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation

Retrieved on: 
Saturday, March 4, 2023

The TRILUMINATE™ Pivotal study evaluates the superiority of TriClip compared to medical therapy in treating patients with severe, symptomatic tricuspid regurgitation (TR) who are at intermediate or greater risk for open-heart surgery.

Key Points: 
  • The TRILUMINATE™ Pivotal study evaluates the superiority of TriClip compared to medical therapy in treating patients with severe, symptomatic tricuspid regurgitation (TR) who are at intermediate or greater risk for open-heart surgery.
  • Mortality or tricuspid valve surgery and heart failure hospitalizations did not appear different between the groups at one year.
  • At 30 days, only 1.7% of patients who received the device experienced major adverse events, with no urgent surgery or endocarditis.
  • Abbott will also be presenting at ACC late-breaking five-year results from its landmark COAPT™ trial of the MitraClip™ TEER device for functional mitral regurgitation in heart failure.